EZH2-mediated upregulation of ROS1 oncogene promotes oral cancer metastasis
Oncogene Aug 24, 2017
Shih CH, et al. – Here the scientists introduced an oncogene, ROS1, as an important driver for oral squamous cell carcinoma (OSCC) metastasis. They indicated ROS1 as a candidate biomarker and therapeutic target for OSCC. In addition, they suggested that co–targeting of ROS1 and EGFR could potentially offer an effective oral cancer therapy.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
